Australia markets closed

Vivoryon Therapeutics N.V. (VVY.AS)

Amsterdam - Amsterdam Delayed price. Currency in EUR
Add to watchlist
2.6300-0.0200 (-0.75%)
As of 12:01PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
-3,620
-3,620
0
10,764
0
-
Cost of revenue
-525
-525
0
1,569
0
-
Gross profit
-3,095
-3,095
0
9,196
0
-
Operating expenses
Research development
17,637
17,637
20,224
17,452
13,210
-
Selling general and administrative
3,272
3,272
4,898
2,354
1,523
-
Total operating expenses
25,700
25,700
29,059
22,094
16,011
-
Operating income or loss
-28,795
-28,795
-29,059
-12,898
-16,011
-
Interest expense
56
56
24
24
23
-
Income before tax
-28,576
-28,576
-28,355
-12,223
-16,510
-
Income tax expense
-234
-234
-199
432
0
-
Income from continuing operations
-28,342
-28,342
-28,156
-12,655
-16,510
-
Net income
-28,342
-28,342
-28,156
-12,655
-16,510
-
Net income available to common shareholders
-28,342
-28,342
-28,156
-12,655
-16,510
-
Basic EPS
-1.12
-
-1.28
-0.63
-0.83
-0.62
Diluted EPS
-1.12
-
-1.28
-0.63
-0.83
-0.62
Basic average shares
23,711
-
22,020
20,000
19,975
12,550
Diluted average shares
23,711
-
22,020
20,000
19,975
12,550